HK192995A - Bordetella pertussis toxin with altered toxicity - Google Patents

Bordetella pertussis toxin with altered toxicity

Info

Publication number
HK192995A
HK192995A HK192995A HK192995A HK192995A HK 192995 A HK192995 A HK 192995A HK 192995 A HK192995 A HK 192995A HK 192995 A HK192995 A HK 192995A HK 192995 A HK192995 A HK 192995A
Authority
HK
Hong Kong
Prior art keywords
bordetella pertussis
pertussis toxin
polypeptides
toxicity
altered
Prior art date
Application number
HK192995A
Other languages
English (en)
Inventor
Mariagrazia Pizza
Rino Rappuoli
Antonella Bartoloni
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11196853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK192995(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sclavo Spa filed Critical Sclavo Spa
Publication of HK192995A publication Critical patent/HK192995A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK192995A 1987-11-02 1995-12-21 Bordetella pertussis toxin with altered toxicity HK192995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22481/87A IT1223334B (it) 1987-11-02 1987-11-02 Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse

Publications (1)

Publication Number Publication Date
HK192995A true HK192995A (en) 1995-12-29

Family

ID=11196853

Family Applications (1)

Application Number Title Priority Date Filing Date
HK192995A HK192995A (en) 1987-11-02 1995-12-21 Bordetella pertussis toxin with altered toxicity

Country Status (9)

Country Link
US (1) US7410646B1 (de)
EP (1) EP0322533B1 (de)
JP (2) JP2728275B2 (de)
AT (1) ATE123062T1 (de)
CA (1) CA1341582C (de)
DE (1) DE3853876T2 (de)
ES (1) ES2072857T3 (de)
HK (1) HK192995A (de)
IT (1) IT1223334B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0168039B1 (ko) * 1987-09-04 1999-01-15 로버트 디. 웨스트 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US5332583A (en) * 1987-11-24 1994-07-26 Connaught Laboratories Limited Vaccine containing genetically-detoxified pertussis holotoxin
US5244657A (en) * 1987-11-24 1993-09-14 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
IT1223529B (it) * 1987-12-18 1990-09-19 Sclavo Spa Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse
AP8900132A0 (en) * 1988-07-22 1991-01-14 Smithkline Biolog Bordetella pertussis vaccine
ES2078258T3 (es) * 1989-04-28 1995-12-16 Sclavo Spa Mutantes de toxina pertussica, cepas de bordetella capaces de producir tales mutantes y su uso en el desarrollo de vacunas antipertussicas.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
US5856122A (en) * 1993-08-24 1999-01-05 University Of Alberta Modification of pertussis toxin
GB9908263D0 (en) * 1999-04-13 1999-06-02 Binding Site The Limited Eliciting improved immune responses
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
GB0313242D0 (en) * 2003-06-09 2003-07-16 Imp College Innovations Ltd Pulmonary immunopathology
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
PT2066344E (pt) 2006-09-07 2011-07-05 Glaxosmithkline Biolog Sa Vacina de combinação de poliovírus inactivado
UY31064A1 (es) 2007-05-02 2009-01-05 Glaxosmithkline Biolog Sa Vacuna
TW201103980A (en) 2009-07-08 2011-02-01 Abbott Biologicals Bv Viral vaccine and use thereof
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
EP3620172A1 (de) * 2012-10-12 2020-03-11 GlaxoSmithKline Biologicals SA Unvernetzte azelluläre pertussis-antigene zur verwendung in kombinationsimpfstoffen
ES2597832T3 (es) 2013-03-08 2017-01-23 Janssen Vaccines & Prevention B.V. Vacuna acelular contra la tosferina
CA2919773A1 (en) 2013-08-05 2015-02-12 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
DE3781541T2 (de) * 1986-12-23 1993-05-06 Univ Leland Stanford Junior Modifiziertes pertussistoxin.
KR0168039B1 (ko) * 1987-09-04 1999-01-15 로버트 디. 웨스트 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin

Also Published As

Publication number Publication date
EP0322533B1 (de) 1995-05-24
US7410646B1 (en) 2008-08-12
EP0322533A1 (de) 1989-07-05
JPH09157293A (ja) 1997-06-17
IT8722481A0 (it) 1987-11-02
JPH01165370A (ja) 1989-06-29
JP2728275B2 (ja) 1998-03-18
CA1341582C (en) 2008-10-07
IT1223334B (it) 1990-09-19
DE3853876D1 (de) 1995-06-29
ES2072857T3 (es) 1995-08-01
DE3853876T2 (de) 1995-10-05
ATE123062T1 (de) 1995-06-15
JP2857105B2 (ja) 1999-02-10

Similar Documents

Publication Publication Date Title
HK192995A (en) Bordetella pertussis toxin with altered toxicity
ATE123065T1 (de) Proteine und deren herstellung.
DE69334155D1 (de) Rekombinante mutanten zur induktion spezifischer immunantworten
SE8802165L (sv) Foerbaettringar i och haenfoerande till fermentation
HK17096A (en) Pertussis toxin mutants bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
EP0232229A3 (en) Cloning and expression of bordetella pertussis toxin-encoding dna
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
DK0500917T3 (da) Vacciner og fremgangsmåder baseret på rekombinante herpes simplex virusser.
GR3006444T3 (de)
CY1934A (en) Process
IT1202612B (it) Plasmidi ricombinanti utili per l'espressione in bacillus di proteine eterologhe
DE3570694D1 (en) Recombinant saccharomyces
DK53488A (da) Cytochrom-p-450-enzymer samt fremgangsmaade til fremstilling heraf
DK251385D0 (da) Kultur af bacillus subtilis mutant og fremgangsmaade til fremstillingderaf samt fremgangsmaade til anvendelse deraf
GB9027901D0 (en) Acellular vaccine
MX9601087A (es) Gen que participa en el mecanismo de secrecion de esterasa.
AU7818391A (en) Method containing a biological system comprising bacterial cells, recombinant plasmid, recombinant bacterial cells and a vaccine comprising a population of such cells

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20081024